Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare
Clinical trial NCT05580042 · COMPLETED
Trial details
- NCT number
- NCT05580042
- Sponsor
- TWi Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2023-11-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.